Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Well Crow,

<< Previous

Bullboard Posts

Next >>

Comment by crow27on Feb 19, 2021 4:12pm

187 Views

Post# 32612864

RE:Well Crow,

I have been telling folks to buy on the dips. When it was in the $4.00 range I was telling people to buy, buy, buy. And then it went down to below $3.50 and I was telling folks to buy more. Now looking back did the Crow really eat any Crow??
Now it is playing all over again but in the $7.00 and $6.00 range. The only difference and BIG difference is that this company is 10x better today than when it was $4.00
Lets see where we are in a little while? I continue to tell people to BUY THE DIPS.
Fantastic news is just around the corner and it will not matter if you bought at $7.50 or $6.00.
The Crow says Buy, Buy, Buy. When it turns these days will be gone forever.

<< Previous

Bullboard Posts

Next >>

Thematic Insights report: The Hard Asset Century